Is Sudden Death Hereditary? A Family Tragedy Awakens the Entire Family! Genetic Screening Builds a Stronger Lifeline for High-Risk Cardiovascular Individuals

The sudden death of a relative triggered Mr. U's coronary heart disease symptom.

Case Overview

The sudden death of a relative triggered Mr. U's coronary heart disease symptom.

Cause & Challenge

A month ago, Mr. U (pseudonym), a patient from Bangladesh, witnessed his brother's sudden death. Overwhelmed by grief and panic, he suddenly experienced shortness of breath, dizziness, and a sharp rise in blood pressure. Harbor Health quickly arranged for Mr. U to receive emergency treatment at Beijing Fuwai Hospital. Subsequently, Mr. U was diagnosed with coronary heart disease, stage 3 hypertension (very high risk), hyperlipidemia, and hyperuricemia, and his condition became critical. Under anesthesia, Mr. U underwent coronary angiography and interventional treatment, successfully implanting two stents, after which his condition improved. This sudden cardiac crisis was not accidental—Harbor Health discovered that most of Mr. U's relatives who accompanied him to the hospital had abnormal conditions such as obesity and high blood pressure, which are extremely rare among people of the same age.

Why China

Harbor Health connected the patient with appropriate Chinese medical resources, coordinated expert review, hospital access, interpretation, and treatment planning based on the case needs.

Treatment & Benefits

Family-risk screening and preventive cardiovascular planning.

Full Story

A month ago, Mr. U (pseudonym), a patient from Bangladesh, witnessed his brother's sudden death. Overwhelmed by grief and panic, he suddenly experienced shortness of breath, dizziness, and a sharp rise in blood pressure. Harbor Health quickly arranged for Mr. U to receive emergency treatment at Beijing Fuwai Hospital. Subsequently, Mr. U was diagnosed with coronary heart disease, stage 3 hypertension (very high risk), hyperlipidemia, and hyperuricemia, and his condition became critical.

Under anesthesia, Mr. U underwent coronary angiography and interventional treatment, successfully implanting two stents, after which his condition improved. This sudden cardiac crisis was not accidental—Harbor Health discovered that most of Mr. U's relatives who accompanied him to the hospital had abnormal conditions such as obesity and high blood pressure, which are extremely rare among people of the same age.

Based on the family history of his brother's sudden death, Harbor Health was highly alarmed: this was not an ordinary cardiovascular problem, but a genetic risk hidden in the genes, which was quietly threatening the lives of the entire family! Therefore, Harbor Health organized a team of experts to analyze the potential risks of cardiovascular disease in Mr. U’s family, and with their consent, quickly carried out comprehensive genetic testing for Mr. U and his relatives.

Cardiovascular Gene Screening: Deciphering Genetic Secrets to "See Risks in Advance"

Cardiovascular disease is the result of the long-term combined effects of numerous adverse factors. Besides traditional risk factors such as hypertension, hyperlipidemia, hyperglycemia, smoking, unhealthy diet, lack of exercise, and obesity, genetic factors also play a crucial role in the development of cardiovascular disease. Some cardiovascular diseases are caused by mutations in a single gene; these are called monogenic hereditary cardiovascular diseases. There are hundreds of such diseases, including certain types of cardiomyopathy and hereditary arrhythmias, and they often exhibit familial aggregation. Clinically, monogenic hereditary cardiovascular diseases often have an early onset and are associated with serious consequences such as sudden death, early-onset heart failure, early-onset coronary heart disease, and refractory hypertension, causing severe harm and a heavy burden on patients, their families, and society.

Convenient testing: Only peripheral blood and/or oral swabs are required; non-invasive and painless.

Precise Technology: By combining targeted region capture and high-throughput sequencing technologies, the base sequences of exon regions and intron regions within 50 bp of all known human genes (over 20,000 genes) can be determined. The exons detected represent almost all gene exons, which is, the regions in the human genome that are translated into proteins.

Comprehensive protection: The testing scope includes, but is not limited to, more than 3,000 single-gene genetic diseases in twelve major categories. It not only comprehensively analyzes the potential risk of cardiovascular diseases caused by genetic factors (as shown in the table below), but also detects single-gene genetic diseases of the body's renal system, neuromuscular system, skeletal system, endocrine system, blood system, immune system, skin system, and sensory system.

Taking the cardiovascular system as an example, what is the role of genetic testing in specific hereditary cardiovascular diseases?

Note: +++, strongly recommended/very useful; ++, recommended/useful; +, worth considering/potentially useful; -, not recommended/useless. Only some single-gene hereditary cardiovascular diseases are listed here; please consult your clinician for more disease types.

One test protects the whole family's four core benefits:

Comprehensive genetic screening: It is estimated that protein-coding regions of the human genome contain approximately 85% of pathogenic mutations. Whole-exome sequencing has been successfully applied to identify inherited and de novo mutations in a wide variety of autosomal dominant, recessive, and X-linked diseases, enabling comprehensive screening for hereditary single-gene diseases and facilitating early intervention and treatment.

Personalized precision medicine: Personalized precision medicine can more accurately assess the efficacy and potential adverse reactions of long-term treatment drugs for individuals, reduce the risk of adverse reactions, assist clinical adjustments to dosage, and ensure safe and effective treatment.

Accurate pathogenicity interpretation and family early warning: Based on guidelines and rules, the pathogenicity of variants is accurately interpreted to ensure the reliability of test results. Early screening is conducted for high-risk family members of patients, and close monitoring and early intervention are provided for family members carrying pathogenic mutations.

Precise genetic risk assessment to prevent heredity: Professional and accurate genetic risk assessment can provide early warning and intervention to address potential health problems. For patients with clearly identified pathogenic mutations and serious disease consequences, early pregnancy testing or preimplantation genetic diagnosis can guide fertility and prevent the transmission of the disease to offspring.

Awakening After Tragedy: Genetic Testing Provides a "Life Protection Umbrella" for Families

Based on the genetic testing results, Harbor Health organized a team of medical experts to develop a comprehensive routine monitoring plan for Mr. U and his family. For relatives exhibiting adverse symptoms, they developed scientifically sound medication and management plans to control genetic risks at their source and safeguard the entire family's health. Drawing on Mr. U and his family's experience, Harbor Health urges those with early-onset cardiovascular disease, a family history of the disease, or multi-system abnormalities to undergo cardiovascular disease genetic testing as early as possible. This includes:

For patients clinically diagnosed or suspected of having the following single-gene hereditary cardiovascular diseases, especially those with one or more of the following conditions, genetic testing is recommended: 1) young age of onset (e.g., less than 50 years old); 2) family history of similar cardiovascular diseases or family history of sudden death of unknown cause; 3) syndrome manifestations or multi-system abnormalities.

Let's use scientific methods to decipher the secrets of genes and prevent unexpected and serious events from happening!